Barclays analyst Matt Miksic initiates coverage on Edwards Lifesciences (NYSE: EW) with a Overweight rating and a price target of $110.00.

For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.

Shares of Edwards Lifesciences closed at $87.23 yesterday.